Empery Asset Management »

Lantern Pharma shares owned by Empery Asset Management

Quarter-by-quarter ownership of Lantern Pharma (LTRN) shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Lantern Pharma

Tip: Access up to 7 years of quarterly data

All positions including Lantern Pharma held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lantern Pharma by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.5M 843k 4.17

More positions owned by Empery Asset Management

X4 Pharmaceuticals Com New (XFOR)
Empery Digital Com New (EMPD)
Nervgen Pharma Ord (NGEN)
Precision Biosciences Com New (DTIL)
Clene Com New (CLNN)
Annovis Bio (ANVS)
Lantern Pharma (LTRN)
Amc Entmt Hldgs Cl A New (AMC)
Tenaya Therapeutics (TNYA)
One And One Green Technologi Usd Cl A Ord Shs (YDDL)
Cyngn Inc Com Par $0 00001 (CYN)
Venu Hldg Corp (VENU)
Greenland Energy *w Exp 04/21/203
Ur-energy (URG)
Satellos Bioscience (MSLE)

View all positions for Empery Asset Management

Top funds holding Lantern Pharma

BIOS Capital Management
Empery Asset Management
Vanguard Capital Management
Renaissance Technologies
CM Management
Geode Capital Management
Westside Investment Management
Voss Capital
Vanguard Fiduciary Trust
BlackRock
Goss Wealth Management
Horizon Kinetics Asset Management
Davenport & Co
State Street Corporation
Bank of New York Mellon

View all funds holding Lantern Pharma